Bempedoic acid sales will expand through 2036, with 99.5% or higher at 70.0% of the purity grade category and hypercholesterolemia at 68.0% of application demand in 2026. The market is estimated at USD 8.26 million in 2026 and is forecast to record a 7.9% CAGR between 2026 and 2036.